Details for New Drug Application (NDA): 010210
✉ Email this page to a colleague
NDA 010210 describes METIMYD, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the METIMYD profile page.
The generic ingredient in METIMYD is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
The generic ingredient in METIMYD is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for 010210
| Tradename: | METIMYD |
| Applicant: | Schering |
| Ingredient: | prednisolone acetate; sulfacetamide sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.5%;10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.5%;10% | ||||
| Approval Date: | Sep 9, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
